Arda Therapeutics
Arda Therapeutics is a San Carlos, California biotech company founded in 2021 that develops targeted cell depletion therapies for chronic disease. Rather than modulating the proteins that pathogenic cells produce, Arda uses a single-cell sequencing and computational discovery engine to map disease-specific cell states, identify surface markers on harmful cells, and design targeted biologics that selectively deplete them across fibrotic, autoimmune, and metabolic conditions. Backed by a $43M Series A led by a16z Bio + Health with GV, Two Sigma Ventures, Eli Lilly and others. This API Evangelist profile tracks the company's public developer and web surface; Arda currently publishes a corporate marketing site with no public developer API.
Arda Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Cell Depletion, and Single-Cell.
Arda Therapeutics’ developer surface includes product news and 7 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 6
The organization behind the API
Other 1
Properties that don't map to a standard resource type